HOME
|
CONTACT
|
SITEMAP
HOME
CORPORATE
VISION
MANAGEMENT TEAM
BOARD OF DIRECTORS
CLINICAL ADVISORY BOARD
SCIENTIFIC ADVISORY BOARD
CORPORATE GOVERNANCE
TECHNOLOGY
NTx®-265 (Stroke)
NTx®-428 (Brain Trauma)
NTx®-488 (Multiple Sclerosis)
PUBLICATIONS
MEDIA CENTRE
GLOSSARY
INVESTORS
STOCK INFORMATION
FINANCIAL REPORTS
STROKE MARKET
SHAREHOLDER SERVICES
INVESTOR CONTACT
NEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
TSX - Venture:
SSS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
PRESS RELEASES
Currently Viewing:
Latest Press Releases
Press releases from 2010
Press releases from 2009
Press releases from 2008
Press releases from 2007
Press releases from 2006
Press releases from 2005
Press releases from 2004
Aug 26, 2010
Stem Cell Therapeutics Corp. Announces Q2 2010 Financial Results
Aug 13, 2010
Stem Cell Therapeutics Corp.: Traumatic Brain Injury (TBI) Clinical Study Gains IRB Approval at University of Calgary
Aug 10, 2010
Stem Cell Therapeutics Corp.: Corporate Update
Jun 25, 2010
Stem Cell Therapeutics Corp. Corporate Update
Jun 17, 2010
Stem Cell Therapeutics Corp. Continues Its Validation Review of the Modified REGENESIS Phase IIb Stroke Trial
Jun 08, 2010
Stem Cell Therapeutics Corp. Announces the Issuance of United States Patent
May 25, 2010
Stem Cell Therapeutics Corp. Announces Top-Line Results for the Modified REGENESIS Phase IIb Stroke Trial
May 19, 2010
Stem Cell Therapeutics Corp. Announces Voting Results and Q1 2010 Financial Results
May 19, 2010
Stem Cell Therapeutics Corp. Announces the Date for the Release of Top-Line Results in the Modified REGENESIS Phase IIb Stroke Trial
Apr 28, 2010
Stem Cell Therapeutics Corp. Announces the Publication of a Dundee Capital Markets Report: SSS- Stem Cell Therapeutics Corp.- Near Term High Risk/Reward Data
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade:
0.065
Change:
+8.33%
Volume:
243549
Date:
9/3/2010
Time:
3:48pm
Note: Quotes are delayed. For informational purposes only.
LETTER TO SHAREHOLDERS
+
2009 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved
Home
|
Site Map
|
Terms Of Use
|
Contact Us